60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis
Case reports published in medical literature suggest that tafenoquine combined with standard-of-care treatment exhibits a high cure rate in ...
Le Lézard3h
Cell Therapy Technologies Market to Hit US$ 6.80 Billion by 2029 with 11.0% CAGR | MarketsandMarketstm
The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of ...